Artemis Hospitals
Follicular lymphoma treatment cost in India typically runs between AUD $15,821 and AUD $37,107 for advanced procedures like an autologous bone marrow transplant. Primary diagnostic steps such as a sentinel lymph node biopsy cost from AUD $144 to AUD $144. Total expenses depend on the medication cycles and hospital tier, though patients generally save 60–80% compared to Australia. Delhi, Mumbai, and Bengaluru are the leading cities for this care.
Typical Follicular Lymphoma Treatment Costs in India
Bookimed Expert Insight: Patients requiring bone marrow transplants find the best value at integrated cancer centres. Global Hospital Chennai and Apollo Hospital Indraprastha manage over 1,000,000 patients annually, ensuring high clinical experience. For complex blood disorders, specialists like Dr. Girish Badarkhe offer 10+ years of hematology expertise. Larger networks like Manipal Hospitals provide IBM Watson decision support to help tailor precise treatment plans.
| India | Thailand | Turkey | |
| Radiation therapy for colorectal cancer | from AUD $4,602 | from AUD $7,910 | from AUD $10,068 |
| Chemotherapy for breast cancer | from AUD $5,034 | from AUD $4,315 | from AUD $1,726 |
| Bone marrow transplantation | from AUD $21,574 | from AUD $71,913 | from AUD $51,777 |
| Autologous bone marrow transplantation | from AUD $15,821 | from AUD $57,530 | from AUD $45,305 |
| Allogenic bone marrow transplantation from an unrelated donor | from AUD $40,271 | from AUD $215,739 | from AUD $115,061 |
No hidden fees – just official clinic prices. Pay at the clinic for Follicular lymphoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Follicular lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Follicular lymphoma treatment journey.
Professor Gaurav Kharya leads the hemato-oncology and bone marrow transplant unit at Artemis Hospitals, specializing in complex blood disorder treatments.
Professor Deenadayalan Munirathnam is a specialist in blood-related cancers and bone marrow transplant procedures at Global Hospital Mumbai.
Professor Girish Badarkhe leads the haematology department at HCG Manavata Cancer Centre, specialising in complex lymphoma care and bone marrow transplants.
Follicular lymphoma is manageable as a chronic condition in India rather than being cured in the traditional sense. Stage 1 cases may reach long-term remission through radiation. Advanced cases focus on functional cures. These involve immunotherapy, CAR T-cell therapy, and bone marrow transplants at JCI-accredited centres.
Bookimed Expert Insight: Indian oncology centres often offer high-density radiation technologies like Tomotherapy-H and 4D radiotherapy. These systems track tumour movement in real-time. This precision is vital for treating localised follicular lymphoma while sparing healthy organs. Facilities like HCG Manavata Cancer Centre have handled over 25,000 radiotherapy cases. This volume suggests a level of technical refinement. It supports better long-term remission outcomes for patients.
Patient Consensus: Patients in India find the care matches Western standards. They note the massive cost advantage for major treatments like chemotherapy. They also highlight that lifelong monitoring for relapse is a practical reality. Many feel international protocols like R-CHOP are delivered with high expertise.
CAR-T cell therapy is available in India for relapsed or refractory follicular lymphoma. The indigenous therapy NexCAR19 (Talicabtagene autoleucel) is approved for B-cell lymphomas. Specialist clinics in Mumbai, Nashik, and Bengaluru provide this autologous cell therapy. It is suitable for patients aged 15 and older.
Bookimed Expert Insight: NexCAR19 is widely cited as costing A$45,000 to A$150,000. But the real value lies in the facility accreditation. For follicular lymphoma, patients should prioritise centres like HCG Manavata. This hospital houses an FDA-audited research institute. Its specialists have 10+ years of experience in cellular therapies.
Patient Consensus: Patients note that NexCAR19 is a viable second-line option for refractory cases in India. They recommend planning for a 2–4 week stay for T-cell collection and infusion.
Standard follicular lymphoma treatment in India follows international protocols including active surveillance, chemoimmunotherapy, and radiation. Leading JCI-accredited hospitals such as Artemis Hospitals and Apollo Hospital Indraprastha provide specialised care. Treatment often includes rituximab biosimilars and CAR T-cell therapy for refractory cases.
Bookimed Expert Insight: Indian cancer centres often use rituximab biosimilars to maintain high treatment standards. This makes maintenance therapy more accessible for international patients. Dr Girish Badarkhe at HCG Manavata Cancer Centre also performs allogeneic and haploidentical transplants. These options provide vital alternatives when frontline chemoimmunotherapy does not reach desired outcomes.
Patient Consensus: Patients note that Indian oncologists often follow NCCN or ESMO guidelines for grade 3A cases. Many recommend confirming if travel insurance covers pre-existing cancer care before travelling to India.
Follicular lymphoma treatment in India typically lasts between 4 months and 2 years. Induction chemotherapy generally requires 4 to 6 months of active treatment. Many patients then have maintenance therapy for up to 2 years. This extends remission periods and maintains health.
Bookimed Expert Insight: Indian centres like HCG Manavata Cancer Centre and Global Hospital Chennai specialise in high-volume haematology. These facilities manage over 2 million patients annually across their networks. This massive case volume lets Indian oncologists refine protocols for rare lymphoma grades. Patients benefit from this concentrated expertise through precise diagnostic staging. This uses accurate PET-CT and 4D radiotherapy units.
Patient Consensus: Patients note that while induction therapy ends quickly, symptoms like bone pain can linger for 18 months. Those treated in India emphasise confirming if maintenance protocols align with Australian standards. This helps ensure long-term remission.
India houses leading oncology centres like Global Hospital Chennai and HCG Manavata Cancer Centre. These hospitals provide therapies including CAR T-cell therapy and bone marrow transplants. Facilities often hold JCI and NABH accreditations. Indian specialists treat complex lymphomas. They use precise tools like TomoTherapy-H and TrueBeam STx technology.
Bookimed Expert Insight: Lymphoma care in India is increasingly centralised. It is moving to specialised cancer hubs rather than general hospitals. HCG Manavata Cancer Centre has performed over 65,000 cancer surgeries. Clinics like Manipal Goa Hospital offer dedicated Bone Marrow Transplant units. These high volumes allow Indian specialists to maintain expertise in rare lymphoma subtypes. Patients can access diagnostics like 4D radiotherapy and IBM Watson for Oncology. These are available at costs significantly lower than in Western Europe.
Patient Consensus: Patients find that Indian hospitals provide standard care protocols. This often includes 6 chemotherapy rounds for Grade 3A disease. Practical support like free airport transfers and visa assistance is common. People also note that newer, non-traditional therapies are sometimes accessible. They are available through specific clinical pathways.